More than 200 newly appointed national-level drug inspectors solemnly took their oath of office in Beijing.

Classification： Company News

Release time：2016-12-30 15:03

On the morning of December 29, the State Administration for Market Regulation’s National Medical Products Administration held its first certificate-awarding and oath-taking ceremony for newly appointed national-level drug inspectors in Beijing. Director Bi Jingquan attended and addressed the gathering, while Deputy Director Wu Zhen presided over the oath‑taking ceremony.

Bi Jingquan first extended his congratulations to the newly appointed national-level drug inspectors. He emphasized that these inspectors embody the image, competence, and standards of China’s food and drug regulatory authorities—honoring them not only with prestige but also with a profound sense of responsibility. Inspectors must keep their oath firmly in mind, fulfill their duties conscientiously, live up to their mission, safeguard the profession’s reputation, cherish their honor, and serve as steadfast guardians of public health. Above all, inspectors must uphold principles and leave no issue that could compromise the quality or efficacy of medicines unaddressed. During inspections at the drug registration stage, it is essential to rigorously ensure the authenticity, consistency, and feasibility of the proposed marketing scale, thereby safeguarding the safe launch of drugs. In follow-up inspections under the Good Manufacturing Practice (GMP) framework, it is crucial to maintain ongoing compliance throughout the manufacturing process and to ensure that data are complete, accurate, and traceable. In cause‑based inspections, inspectors should be adept at exposing hidden practices and resolutely crack down on illegal and non‑compliant activities. Inspectors must strictly adhere to discipline. When carrying out inspection tasks assigned by the General Administration, they shall comply with deployment and scheduling and follow instructions; they must fulfill their inspection responsibilities in strict accordance with all relevant regulatory requirements governing drug research and development, manufacturing, and marketing; they are required to complete the prescribed inspection workload, continuously acquire new knowledge, and maintain a keen awareness of inspection matters at all times; and they must observe confidentiality regulations.

Bi Jingquan emphasized that inspectors must be loyal to the Party and the people, uphold the law, and dedicate themselves to the cause of food and drug regulation. They should possess the ability to discern right from wrong, identify problems, and conduct investigations and handle cases; national-level inspectors, in particular, must also be capable of researching inspection methodologies and developing training materials. Inspectors are expected to have a solid grasp of specialized knowledge in food science and pharmaceutical science, as well as basic proficiency in computer applications, law, and financial analysis. They should cultivate a work style characterized by scientific pragmatism, rigorous attention to detail, and decisive action. Moreover, they must embody integrity, adhere to principles, remain upright and impartial, and maintain an unwavering commitment to justice. Finally, they must firmly uphold the bottom line of impartiality, refraining from bending the law for personal gain, accepting bribes, or disclosing confidential information.

Bi Jingquan emphasized that the CPC Central Committee and the State Council attach great importance to building a robust team of food and drug inspectors. The “Healthy China 2030” Planning Outline, the National Economic and Social Development 13th Five-Year Plan Outline, and the State Council’s Opinions on Reforming the Review and Approval System for Drugs and Medical Devices all underscore the need to establish a professional inspector corps. It is essential to develop a tiered management system for inspectors and ensure clear career advancement pathways, thereby making the inspection profession one that offers prospects, opportunities, and room for growth. Furthermore, addressing inspectors’ remuneration and benefits will help attract and retain talent, enabling the food and drug regulatory system to achieve both professionalism and specialization within its inspector workforce. More than 200 newly appointed national-level drug inspectors attended the oath‑taking ceremony, while responsible officials from relevant departments, bureaus, and directly affiliated units also participated in the meeting. Pharmaceutical Inspector’s Oath It is understood that China currently has 649 national-level drug inspectors, including 108 international inspectors.

 

Previous: The Fourth Session of the Fourth Members’ Congress of the Pudong Enterprise Federation and the Spring Welcome Gala

Next: “China Smart Pharmaceutical Manufacturing 2025” Summit Forum: The Hangzhou Declaration on “China Smart Pharmaceutical Manufacturing 2025” Was Released

Online Consultation

If you have any questions or need assistance, please feel free to leave your contact information, and we’ll get in touch promptly to help resolve your issue!

Submit